Moderna (MRNA), with its widely used COVID-19 vaccine, rose to prominence during the global pandemic. The stock soared an eye ...

Cancer patients receiving a certain type of immunotherapy were twice as likely to be alive after three years if they received a COVID-19 mRNA vaccine within 100 days of beginning cancer treatment, new ...

The observation also marks a significant step toward a long-awaited universal cancer vaccine to boost the tumor-fighting ...

"mRNA cancer vaccines sensitize tumors to immune checkpoint inhibitors (ICIs) in part by stimulating a surge in inflammatory ...

An analysis of patient records suggests that mRNA covid-19 vaccines boost the immune response to cancerous tumours when given ...

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy ...

Patients with late-stage lung and skin cancer may have just won an unlikely ally: the COVID-19 mRNA vaccine. Researchers at ...

However, the research team head cautioned that it is still too early to recommend the mRNA COVID-19 vaccine as a standard ...

A new study suggests that mRNA vaccines for COVID-19 could help boost the effects of immunotherapy drugs for some cancer patients.

Amid confusion over this year's updated COVID-19 vaccines, we explain what's different this year and who experts say should ...

A large-scale study published in the Journal of the American Medical Association found first-trimester exposure to mRNA COVID ...